피페리딘(Piperidine) 시장 : 2027년까지의 세계 예측

출판 : MarketsandMarkets(마켓츠앤마켓츠)출판년월 : 2022년06월

피페리딘(Piperidine) 시장 : 유형(99% 순도 및 98% 순도), 최종 용도 산업(제약, 농약, 고무 및 기타), 지역(아시아 태평양, 유럽, 북미, 중동, 아프리카, 남미) – 2027년까지의 세계 예측
Piperidine Market by Type (99% Purity and 98% Purity), End Use Industry (Pharmaceutical, Agrochemicals, Rubber, and Others), Region (Asia Pacific, Europe, North America, Middle East & Africa and South America) – Global Forecast to 2027

페이지수 166
도표수 235
구성 영문조사보고서
가격

리포트목차    주문/문의    납기/라이센스안내

Sample Request

The market size for global piperidine market is projected to grow from USD 64 million in 2022 to USD 86 million by 2027, at a CAGR of 5.9% from 2022 to 2027.
The growth of the piperidine market is attributed to their high demand as solvents, base and catalyst in pharmaceutical, agrochemical and others industries.
세계 피페리딘 시장의 시장 규모는 2022년부터 2027년까지 5.9%의 CAGR로 2022년 6,400만 달러에서 2027년에는 8,600만 달러로 성장할 것으로 예상됩니다.
피페리딘 시장의 성장은 제약, 농약 및 기타 산업에서 용매, 염기 및 촉매로서의 높은 수요에 기인합니다.

“99% purity segment to be the largest type of piperidine ”
Piperidine with 99% purity and above is the purest form of piperidine available. The pharmaceutical end-use industry is boosting the demand for piperidine with 99% purity. Some piperidine derivatives, namely, N-Methyl, N-Benzyl piperidone derivatives, are extremely useful and versatile API intermediates in organic synthesis.

“Agrochemicals to be the second-largest segment during the forecast period.”

Agrochemicals refer to the chemical products used in the agriculture field. They are comprised of pesticides, fertilizers, and other plant-growth hormones used in agriculture. The demand for agrochemical products is driven by the increasing global population and requirements to fulfill the increasing demand for food from limited croplands available.

“Asia Pacific to be the largest market for piperidine ”
Emerging economies in the region are expected to experience significant demand for piperidine because of the growing pharmaceutical and agrochemical industries. In addition to this, the growing population in these countries represents a strong customer base. According to the World Bank, Asia Pacific is the world’s fastest-growing region in terms of population and economic growth. Factors such as the ready availability of raw materials and workforce, along with sophisticated technologies and innovations, have driven the economy in the Asia Pacific.

This study has been validated through primaries conducted with various industry experts worldwide. These primary sources have been divided into 3 categories, namely by company, by designation, and by region.
• By Department- Sales/Marketing – 50%, Production – 30%, R&D – 20%
• By Designation- Managers – 50%, CXOs – 30%, Executives– 20%
• By Region- North America- 20%, Europe- 20%, Asia Pacific- 40%, and Rest of World – 20%
The piperidine market comprises major manufacturers, Jubilant Ingrevia Limited (India), Vertellus (US), KOEI Chemical Co. Ltd. (Japan), and BASF (Germany). among others. The study includes an in-depth competitive analysis of these key players in the piperidine market, with their company profiles, and key market strategies.

Research Coverage:
The report covers the piperidine market based on type (98% purity, 99% purity), End-Use Industry (Pharmaceutical,Agrochemicals, Rubber, Others), and region. The report also provides a comprehensive review of market drivers, restraints, opportunities, and challenges in the piperidine market. The report also covers qualitative aspects in addition to the quantitative aspects of these markets.

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest
approximations of the revenue numbers for the overall market and the sub-segments. This report will
help stakeholders understand the competitive landscape and gain more insights to better position
their businesses and plan suitable go-to-market.


목차

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 26)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
TABLE 1 INCLUSIONS & EXCLUSIONS
1.4 MARKET SCOPE
FIGURE 1 PIPERIDINE MARKET SEGMENTATION
1.4.1 YEARS CONSIDERED
1.4.2 REGIONAL SCOPE
1.5 CURRENCY CONSIDERED
1.6 UNIT CONSIDERED
1.7 STAKEHOLDERS
1.8 LIMITATIONS

2 RESEARCH METHODOLOGY (Page No. – 30)
2.1 RESEARCH DATA
FIGURE 2 PIPERIDINE MARKET: RESEARCH DESIGN
2.2 KEY INDUSTRY INSIGHTS
FIGURE 3 DATA VALIDATION THROUGH PRIMARY EXPERTS
TABLE 2 LIST OF STAKEHOLDERS INVOLVED
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS
2.3 BASE NUMBER CALCULATION
2.3.1 SUPPLY-SIDE APPROACH – 1
FIGURE 5 PIPERIDINE MARKET: SUPPLY-SIDE APPROACH – 1
2.3.2 SUPPLY-SIDE APPROACH – 2
FIGURE 6 PIPERIDINE MARKET: SUPPLY-SIDE APPROACH – 2
2.3.3 DEMAND-SIDE APPROACH – 1
FIGURE 7 PIPERIDINE MARKET: DEMAND-SIDE APPROACH – 1
2.4 MARKET SIZE ESTIMATION
2.4.1 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
2.4.2 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.5 TRIANGULATION
2.5.1 SECONDARY DATA
2.5.2 PRIMARY DATA
FIGURE 8 DATA TRIANGULATION
2.6 RESEARCH ASSUMPTIONS & LIMITATIONS
2.6.1 ASSUMPTIONS
2.6.2 RISK ASSESSMENT
TABLE 3 LIMITATIONS & ASSOCIATED RISKS
2.7 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
FIGURE 9 MARKET GROWTH PROJECTIONS FROM GROWTH DRIVERS AND OPPORTUNITIES

3 EXECUTIVE SUMMARY (Page No. – 39)
FIGURE 10 99% PURITY SEGMENT TO DOMINATE OVERALL PIPERIDINE MARKET, 2022–2027
FIGURE 11 PHARMACEUTICAL SEGMENT TO DOMINATE PIPERIDINE MARKET, 2022–2027
FIGURE 12 ASIA PACIFIC DOMINATED PIPERIDINE MARKET IN 2021

4 PREMIUM INSIGHTS (Page No. – 42)
4.1 ASIA PACIFIC TO WITNESS RELATIVELY HIGHER DEMAND FOR PIPERIDINE
FIGURE 13 ASIA PACIFIC OFFERS ATTRACTIVE OPPORTUNITIES IN PIPERIDINE MARKET
4.2 ASIA PACIFIC: PIPERIDINE MARKET, BY END-USE INDUSTRY AND COUNTRY
FIGURE 14 CHINA WAS LARGEST MARKET FOR PIPERIDINE IN 2021
4.3 PIPERIDINE MARKET, BY END-USE INDUSTRY
FIGURE 15 PHARMACEUTICAL SEGMENT TO LEAD OVERALL PIPERIDINE MARKET DURING FORECAST PERIOD
4.4 PIPERIDINE MARKET, BY TYPE
FIGURE 16 99% PURITY TO LEAD PIPERIDINE MARKET DURING FORECAST PERIOD
4.5 PIPERIDINE MARKET, BY COUNTRY
FIGURE 17 INDIA PROJECTED TO WITNESS HIGHEST CAGR FROM 2022 TO 2027

5 MARKET OVERVIEW (Page No. – 45)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PIPERIDINE MARKET
5.2.1 DRIVERS
5.2.1.1 Increasing demand from pharmaceutical industry
5.2.1.2 Increasing agrochemicals consumption in emerging and highly populated countries
5.2.2 RESTRAINTS
5.2.2.1 Rising raw material prices
5.2.3 OPPORTUNITIES
5.2.3.1 Emergence of piperidine and its derivatives as antimetastatic and antiproliferation drug
5.2.4 CHALLENGES
5.2.4.1 Health risks associated with piperidine

6 INDUSTRY TRENDS (Page No. – 48)
6.1 PORTER’S FIVE FORCES ANALYSIS
FIGURE 19 PIPERIDINE MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4 PIPERIDINE MARKET: PORTER’S FIVE FORCE ANALYSIS
6.1.1 BARGAINING POWER OF SUPPLIERS
6.1.2 BARGAINING POWER OF BUYERS
6.1.3 THREAT OF NEW ENTRANTS
6.1.4 THREAT OF SUBSTITUTES
6.1.5 INTENSITY OF COMPETITIVE RIVALRY
6.2 SUPPLY CHAIN ANALYSIS
FIGURE 20 PIPERIDINE SUPPLY CHAIN
6.3 ECOSYSTEM MAPPING
FIGURE 21 PIPERIDINE MARKET: ECOSYSTEM MAP
6.4 TECHNOLOGY ANALYSIS
6.5 CASE STUDY ANALYSIS
6.6 PRICE ANALYSIS
TABLE 5 PIPERIDINE MARKET: PRICE ANALYSIS
6.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS
FIGURE 22 PIPERIDINE MARKET: TRENDS IMPACTING CUSTOMER’S BUSINESS
6.8 KEY CONFERENCES & EVENTS IN 2022–2023
TABLE 6 PIPERIDINE MARKET: DETAILED LIST OF CONFERENCES & EVENTS
6.9 REGULATORY ANALYSIS
6.9.1 REACH
6.9.2 DRUG ENFORCEMENT ADMINISTRATION
6.9.3 OSHA (OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION
6.9.4 FEDERAL FINAL RULE OF HAZARD COMMUNICATION REVISED IN 2012 (HAZCOM 2012)
TABLE 7 SKIN CORROSION/IRRITATION: CATEGORY 1C
6.9.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.10 TRADE ANALYSIS
6.10.1 IMPORT-EXPORT SCENARIO OF PIPERIDINE MARKET
6.10.2 EXPORT SCENARIO OF PIPERIDINE
FIGURE 23 PIPERIDINE MARKET: EXPORTING COUNTRIES
6.10.3 IMPORT SCENARIO OF PIPERIDINE
FIGURE 24 PIPERIDINE MARKET: IMPORTING COUNTRIES
6.11 PATENT ANALYSIS
6.11.1 INTRODUCTION
6.11.2 METHODOLOGY
6.11.3 DOCUMENT TYPE
TABLE 9 PIPERIDINE MARKET: REGISTERED PATENTS
FIGURE 25 PIPERIDINE MARKET: REGISTERED PATENTS
6.11.4 PATENT PUBLICATION TRENDS
FIGURE 26 PIPERIDINE MARKET: PATENT PUBLICATION TRENDS, 2016-2021
6.11.5 INSIGHT
6.11.6 LEGAL STATUS OF PATENTS
FIGURE 27 PIPERIDINE MARKET: LEGAL STATUS
6.11.7 JURISDICTION ANALYSIS
FIGURE 28 PIPERIDINE MARKET: JURISDICTION ANALYSIS
6.11.8 TOP PATENT APPLICANTS
FIGURE 29 PIPERIDINE MARKET: TOP PATENT APPLICANTS
TABLE 10 PIPERIDINE MARKET: LIST OF PATENTS BY CELGENE CORPORATION
TABLE 11 PIPERIDINE MARKET: LIST OF PATENTS BY TAKEDA
TABLE 12 PIPERIDINE MARKET: LIST OF PATENTS BY MERCK SHARP & DOHME
6.11.9 LIST OF TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS
TABLE 13 PIPERIDINE MARKET: LIST TOP 10 PATENT OWNERS IN US
6.12 PIPERIDINE WORLD MERCHANDISE EXPORTS AND IMPORTS
6.12.1 IMPORT-EXPORT SCENARIO OF PIPERIDINE MARKET
6.12.2 TOP EXPORTERS OF PIPERIDINE & ITS SALTS
FIGURE 30 TOP EXPORTERS OF PIPERIDINE IN 2019-2020: SHARE OF WORLD EXPORTS
6.12.3 TOP IMPORTERS OF PIPERIDINE & ITS SALTS
FIGURE 31 TOP IMPORTERS OF PIPERIDINE IN 2019-2020: SHARE OF WORLD IMPORTS
6.12.4 EXPORT FLOW
6.12.5 IMPORT FLOW

7 PIPERIDINE MARKET, BY TYPE (Page No. – 69)
7.1 INTRODUCTION
FIGURE 32 99% PURITY SEGMENT DOMINATED PIPERIDINE MARKET IN 2021
TABLE 14 PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 15 PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
7.2 98% PURITY
7.2.1 WIDELY USED FOR ELASTOMER PROCESSING
TABLE 16 98% PURITY: PIPERIDINE MARKET SIZE, BY REGION, 2020–2027 (USD THOUSAND)
TABLE 17 98% PURITY: PIPERIDINE MARKET SIZE, BY REGION, 2020–2027 (TON)
7.3 99% PURITY
7.3.1 HIGH DEMAND FROM PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
TABLE 18 99% PURITY: PIPERIDINE MARKET SIZE, BY REGION, 2020–2027 (USD THOUSAND)
TABLE 19 99% PURITY: PIPERIDINE MARKET SIZE, BY REGION, 2020–2027 (TON)

8 PIPERIDINE MARKET, BY END-USE INDUSTRY (Page No. – 73)
8.1 INTRODUCTION
FIGURE 33 PHARMACEUTICAL END-USE INDUSTRY TO LEAD PIPERIDINE MARKET
TABLE 20 PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 21 PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
8.2 AGROCHEMICALS
8.2.1 INCREASING GLOBAL POPULATION DRIVING DEMAND FOR AGROCHEMICALS AND, IN TURN, FOR PIPERIDINE
TABLE 22 PIPERIDINE MARKET SIZE IN AGROCHEMICALS, BY REGION, 2020–2027 (USD THOUSAND)
TABLE 23 PIPERIDINE MARKET SIZE IN AGROCHEMICALS, BY REGION, 2020–2027 (TON)
8.3 PHARMACEUTICAL
8.3.1 LARGEST END-USE INDUSTRY OF PIPERIDINE
TABLE 24 PIPERIDINE MARKET SIZE IN PHARMACEUTICAL, BY REGION, 2020–2027 (USD THOUSAND)
TABLE 25 PIPERIDINE MARKET SIZE IN PHARMACEUTICAL, BY REGION, 2020–2027 (TON)
8.4 RUBBER
8.4.1 HIGH DEMAND FOR PIPERIDINE AS VULCANIZATION CATALYST
TABLE 26 PIPERIDINE MARKET SIZE IN RUBBER, BY REGION, 2020–2027 (USD THOUSAND)
TABLE 27 PIPERIDINE MARKET SIZE IN RUBBER, BY REGION, 2020–2027 (TON)
8.5 OTHERS
TABLE 28 PIPERIDINE MARKET SIZE IN OTHER END-USE INDUSTRIES, BY REGION, 2020–2027 (USD THOUSAND)
TABLE 29 PIPERIDINE MARKET SIZE IN OTHER END-USE INDUSTRIES, BY REGION, 2020–2027 (TON)

9 PIPERIDINE MARKET, BY REGION (Page No. – 80)
9.1 INTRODUCTION
FIGURE 34 ARGENTINA TO GROW AT HIGHEST RATE GLOBALLY
TABLE 30 PIPERIDINE MARKET SIZE, BY REGION, 2020–2027 (USD THOUSAND)
TABLE 31 PIPERIDINE MARKET SIZE, BY REGION, 2020–2027 (TON)
9.2 ASIA PACIFIC
FIGURE 35 ASIA PACIFIC: PIPERIDINE MARKET SNAPSHOT
TABLE 32 ASIA PACIFIC: PIPERIDINE MARKET SIZE, BY COUNTRY, 2020–2027 (USD THOUSAND)
TABLE 33 ASIA PACIFIC: PIPERIDINE MARKET SIZE, BY COUNTRY, 2020–2027 (TON)
TABLE 34 ASIA PACIFIC: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 35 ASIA PACIFIC: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 36 ASIA PACIFIC: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 37 ASIA PACIFIC: PIPERIDINE MARKET SIZE, END-USE INDUSTRY, 2020–2027 (TON)
9.2.1 CHINA
9.2.1.1 Largest piperidine market in Asia Pacific
TABLE 38 CHINA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 39 CHINA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 40 CHINA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 41 CHINA: PIPERIDINE MARKET SIZE, END-USE INDUSTRY, 2020–2027 (TON)
9.2.2 INDIA
9.2.2.1 Fastest-growing market in region
TABLE 42 INDIA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 43 INDIA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 44 INDIA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 45 INDIA: PIPERIDINE MARKET SIZE, END-USE INDUSTRY, 2020–2027 (TON)
9.2.3 JAPAN
9.2.3.1 Second-fastest-growing mature pharmaceutical market in world
TABLE 46 JAPAN: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 47 JAPAN: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 48 JAPAN: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 49 JAPAN: PIPERIDINE MARKET SIZE, END-USE INDUSTRY, 2020–2027 (TON)
9.2.4 SOUTH KOREA
9.2.4.1 Growth in pharmaceutical industry to drive the market
TABLE 50 SOUTH KOREA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 51 SOUTH KOREA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 52 SOUTH KOREA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 53 SOUTH KOREA: PIPERIDINE MARKET SIZE, END-USE INDUSTRY, 2020–2027 (TON)
9.2.5 ASEAN COUNTRIES
9.2.5.1 Rapid urbanization to be major market driver
TABLE 54 ASEAN COUNTRIES: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 55 ASEAN COUNTRIES: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 56 ASEAN COUNTRIES: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY 2020–2027 (USD THOUSAND)
TABLE 57 ASEAN COUNTRIES: PIPERIDINE MARKET SIZE, END-USE INDUSTRY 2020–2027 (TON)
9.2.6 REST OF ASIA PACIFIC
TABLE 58 REST OF ASIA PACIFIC: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 59 REST OF ASIA PACIFIC: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 60 REST OF ASIA PACIFIC: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 61 REST OF ASIA PACIFIC: PIPERIDINE MARKET SIZE, END-USE INDUSTRY, 2020–2027 (TON)
9.3 EUROPE
TABLE 62 EUROPE: PIPERIDINE MARKET SIZE, BY COUNTRY, 2020–2027 (USD THOUSAND)
TABLE 63 EUROPE: PIPERIDINE MARKET SIZE, BY COUNTRY, 2020–2027 (TON)
TABLE 64 EUROPE: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 65 EUROPE: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 66 EUROPE: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 67 EUROPE: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.3.1 GERMANY
9.3.1.1 Germany to lead market for piperidine in Europe
TABLE 68 GERMANY: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 69 GERMANY: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 70 GERMANY: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 71 GERMANY: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.3.2 ITALY
9.3.2.1 Pharmaceutical and agrochemicals industries to propel growth of piperidine market
TABLE 72 ITALY: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 73 ITALY: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 74 ITALY: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 75 ITALY: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.3.3 FRANCE
9.3.3.1 Growing pharmaceutical industry to drive market
TABLE 76 FRANCE: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 77 FRANCE: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 78 FRANCE: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 79 FRANCE: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)

9.3.4 SPAIN
9.3.4.1 Increase in production and exports of agriculture products to propel growth of piperidine
TABLE 80 SPAIN: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 81 SPAIN: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 82 SPAIN: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 83 SPAIN: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.3.5 UK
9.3.5.1 Increasing government investment in pharmaceutical industry to offer opportunities for piperidine market
TABLE 84 UK: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 85 UK: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 86 UK: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 87 UK: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.3.6 RUSSIA
9.3.6.1 Growing food export to support market growth
TABLE 88 RUSSIA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 89 RUSSIA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 90 RUSSIA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 91 RUSSIA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.3.7 REST OF EUROPE
TABLE 92 REST OF EUROPE: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 93 REST OF EUROPE: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 94 REST OF EUROPE: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 95 REST OF EUROPE: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.4 NORTH AMERICA
TABLE 96 NORTH AMERICA: PIPERIDINE MARKET SIZE, BY COUNTRY, 2020–2027 (USD THOUSAND)
TABLE 97 NORTH AMERICA: PIPERIDINE MARKET SIZE, BY COUNTRY, 2020–2027 (TON)
TABLE 98 NORTH AMERICA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 99 NORTH AMERICA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 100 NORTH AMERICA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 101 NORTH AMERICA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)

9.4.1 US
9.4.1.1 Growing pharmaceutical market and development of new agrochemical products driving market
TABLE 102 US: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 103 US: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 104 US: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 105 US: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.4.2 CANADA
9.4.2.1 Presence of major pharmaceutical companies to boost market
TABLE 106 CANADA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 107 CANADA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 108 CANADA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 109 CANADA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.4.3 MEXICO
9.4.3.1 Growing pharmaceutical production to be key market driver
TABLE 110 MEXICO: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 111 MEXICO: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 112 MEXICO: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 113 MEXICO: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.5 MIDDLE EAST & AFRICA
TABLE 114 MIDDLE EAST & AFRICA: PIPERIDINE MARKET SIZE, BY COUNTRY, 2020–2027 (USD THOUSAND)
TABLE 115 MIDDLE EAST & AFRICA: PIPERIDINE MARKET SIZE, BY COUNTRY, 2020–2027 (TON)
TABLE 116 MIDDLE EAST & AFRICA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 117 MIDDLE EAST & AFRICA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 118 MIDDLE EAST & AFRICA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 119 MIDDLE EAST & AFRICA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.5.1 SAUDI ARABIA
9.5.1.1 Growing domestic pharmaceutical industry boosting demand for piperidine
TABLE 120 SAUDI ARABIA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 121 SAUDI ARABIA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 122 SAUDI ARABIA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 123 SAUDI ARABIA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.5.2 UAE
9.5.2.1 Increasing need for development of healthcare & pharmaceutical sector to drive demand for piperidine
TABLE 124 UAE: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 125 UAE: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 126 UAE: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 127 UAE: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.5.3 SOUTH AFRICA
9.5.3.1 Huge potential for piperidine market in agrochemicals industry
TABLE 128 SOUTH AFRICA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 129 SOUTH AFRICA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 130 SOUTH AFRICA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 131 SOUTH AFRICA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.5.4 REST OF MIDDLE EAST & AFRICA
TABLE 132 REST OF MIDDLE EAST & AFRICA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 133 REST OF MIDDLE EAST & AFRICA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 134 REST OF MIDDLE EAST & AFRICA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 135 REST OF MIDDLE EAST & AFRICA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.6 SOUTH AMERICA
TABLE 136 SOUTH AMERICA: PIPERIDINE MARKET SIZE, BY COUNTRY, 2020–2027 (USD THOUSAND)
TABLE 137 SOUTH AMERICA: PIPERIDINE MARKET SIZE, BY COUNTRY, 2020–2027 (TON)
TABLE 138 SOUTH AMERICA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 139 SOUTH AMERICA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 140 SOUTH AMERICA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 141 SOUTH AMERICA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.6.1 BRAZIL
9.6.1.1 Rising usage of agrochemicals to boost market
TABLE 142 BRAZIL: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 143 BRAZIL: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 144 BRAZIL: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 145 BRAZIL: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.6.2 ARGENTINA
9.6.2.1 Growing agriculture sector to drive market
TABLE 146 ARGENTINA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 147 ARGENTINA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 148 ARGENTINA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 149 ARGENTINA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)
9.6.3 REST OF SOUTH AMERICA
TABLE 150 REST OF SOUTH AMERICA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (USD THOUSAND)
TABLE 151 REST OF SOUTH AMERICA: PIPERIDINE MARKET SIZE, BY TYPE, 2020–2027 (TON)
TABLE 152 REST OF SOUTH AMERICA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (USD THOUSAND)
TABLE 153 REST OF SOUTH AMERICA: PIPERIDINE MARKET SIZE, BY END-USE INDUSTRY, 2020–2027 (TON)

10 COMPETITIVE LANDSCAPE (Page No. – 128)
10.1 INTRODUCTION
FIGURE 36 ACQUISITION WAS KEY STRATEGY ADOPTED BY PLAYERS BETWEEN 2018 AND 2022
10.2 MARKET SHARE ANALYSIS
FIGURE 37 MARKET SHARE OF KEY PLAYERS, 2021
TABLE 154 PIPERIDINE MARKET: DEGREE OF COMPETITION
TABLE 155 STRATEGIC POSITIONING OF KEY PLAYERS
10.3 COMPANY EVALUATION MATRIX
10.3.1 STAR
10.3.2 PERVASIVE
10.3.3 EMERGING LEADER
10.3.4 PARTICIPANT
FIGURE 38 PIPERIDINE MARKET: COMPANY EVALUATION MATRIX, 2021
10.4 STARTUPS AND SMALL AND MEDIUM-SIZED ENTERPRISES (SMES) EVALUATION MATRIX
10.4.1 PROGRESSIVE COMPANIES
10.4.2 RESPONSIVE COMPANIES
10.4.3 DYNAMIC COMPANIES
10.4.4 STARTING BLOCKS
FIGURE 39 PIPERIDINE MARKET: STARTUP AND SMES MATRIX, 2021
10.5 REVENUE ANALYSIS OF TOP PLAYERS
10.6 STRENGTH OF PRODUCT PORTFOLIO
10.7 BUSINESS STRATEGY EXCELLENCE
10.8 KEY MARKET DEVELOPMENTS
10.8.1 DEALS
10.8.2 OTHERS

11 COMPANY PROFILES (Page No. – 138)
(Business Overview, Products and solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY COMPANIES
11.1.1 BASF SE
TABLE 156 BASF SE: COMPANY OVERVIEW
FIGURE 40 BASF SE: COMPANY SNAPSHOT
TABLE 157 BASF SE: PRODUCT OFFERED
11.1.2 KOEI CHEMICAL CO. LTD.
TABLE 158 KOEI CHEMICAL CO. LTD.: COMPANY OVERVIEW
FIGURE 41 KOEI CHEMICAL CO. LTD.: COMPANY SNAPSHOT
TABLE 159 KOEI CHEMICAL CO. LTD.: PRODUCT OFFERED
11.1.3 VERTELLUS
TABLE 160 VERTELLUS: COMPANY OVERVIEW
TABLE 161 VERTELLUS: PRODUCT OFFERED
TABLE 162 VERTELLUS: DEALS
11.1.4 JUBILANT INGREVIA LIMITED
TABLE 163 JUBILANT INGREVIA LIMITED: COMPANY OVERVIEW
FIGURE 42 JUBILANT INGREVIA LIMITED: COMPANY SNAPSHOT
TABLE 164 JUBILANT INGREVIA LIMITED: PRODUCT OFFERED
11.1.5 VASUDHA PHARMA
TABLE 165 VASUDHA PHARMA: COMPANY OVERVIEW
TABLE 166 VASUDHA PHARMA: PRODUCT OFFERED
11.1.6 TAJ PHARMACEUTICALS LTD.
TABLE 167 TAJ PHARMACEUTICALS LTD.: COMPANY OVERVIEW
TABLE 168 TAJ PHARMACEUTICALS LTD.: PRODUCT OFFERED
11.1.7 AVANTOR INC.
TABLE 169 AVANTOR INC.: COMPANY OVERVIEW
FIGURE 43 AVANTOR INC.: COMPANY SNAPSHOT
TABLE 170 AVANTOR INC.: PRODUCT OFFERED
TABLE 171 AVANTOR INC.: DEALS
11.1.8 ALLCHEM LIFESCIENCE PVT. LTD.
TABLE 172 ALLCHEM LIFESCIENCE PVT. LTD.: COMPANY OVERVIEW
TABLE 173 ALLCHEM LIFESCIENCE PVT. LTD.: PRODUCT OFFERED
11.1.9 TORONTO RESEARCH CHEMICALS
TABLE 174 TORONTO RESEARCH CHEMICALS: COMPANY OVERVIEW
TABLE 175 TORONTO RESEARCH CHEMICALS: PRODUCT OFFERED
11.1.10 MERCK KGAA
TABLE 176 MERCK KGAA: COMPANY OVERVIEW
FIGURE 44 MERCK KGAA: COMPANY SNAPSHOT
11.2 OTHER COMPANIES
11.2.1 LANXESS
TABLE 177 LANXESS: BUSINESS OVERVIEW
11.2.2 OTTO CHEMIE PVT. LTD.
TABLE 178 OTTO CHEMIE PVT. LTD.: COMPANY OVERVIEW
11.2.3 SIMSON PHARMA
TABLE 179 SIMSON PHARMA: COMPANY OVERVIEW
11.2.4 ROBINSON BROTHERS LIMITED
TABLE 180 ROBINSON BROTHERS LIMITED: COMPANY OVERVIEW
11.2.5 ALFA AESAR
TABLE 181 ALFA AESAR: COMPANY OVERVIEW
11.2.6 A.R. LIFE SCIENCE PVT. LTD.
TABLE 182 AR LIFE SCIENCE: COMPANY OVERVIEW
11.2.7 AMI ORGANIC LIMITED
TABLE 183 AMI ORGANIC LIMITED: COMPANY OVERVIEW
11.2.8 COREY ORGANICS
TABLE 184 COREY ORGANICS: COMPANY OVERVIEW
11.2.9 J&K SCIENTIFIC
TABLE 185 J&K SCIENTIFIC: COMPANY OVERVIEW
11.2.10 PENTA S.R.O
TABLE 186 PENTA S.R.O: COMPANY OVERVIEW
11.2.11 MUBY CHEMICALS
TABLE 187 MUBY CHEMICALS: COMPANY OVERVIEW
11.2.12 VORTEX PRODUCTS LIMITED
TABLE 188 VORTEX: COMPANY OVERVIEW
11.2.13 SICHUAN HENGKANG SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
TABLE 189 SICHUAN HENGKANG SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.: COMPANY OVERVIEW
11.2.14 VITAL SYNTHESIS
TABLE 190 VITAL SYNTHESIS: COMPANY OVERVIEW
11.2.15 VANAMALI ORGANICS
TABLE 191 VANAMALI ORGANICS: COMPANY OVERVIEW
*Details on Business Overview, Products and solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX (Page No. – 166)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAIL


    • 리포트 제목은 자동으로 입력됩니다.
    • *항목은 필수항목입니다.

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com